Sign inJoin waitlistJoin the waitlist

Scott Borinstein

Associate Program Director, Pediatric Hematology/Oncology Fellowship Program · Vanderbilt University Medical Center

Credentials: · · · · ·

History

Pediatric Hematology/Oncology Fellowship · Vanderbilt University Medical Center
Present
Vanderbilt University Medical Center
Present
Vanderbilt University Medical Center
Present

Seattle Children's Hospital
2008–2011
University of Washington Medical Center - Montlake
2007–2008
University of Washington Medical Center - Montlake
2002–2005
Seattle Children's Hospital
2002–2005
Virginia Commonwealth Univ, Med Coll of Virginia
1998–2002

Research

Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions
Cancer Discovery · 2014 · 359 citations
Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2018 · 257 citations
Adolescent and young adult oncology. Clinical practice guidelines in oncology
Journal of the National Comprehensive Cancer Network · 2012 · 179 citations

DR
Damon Reed
8 papers
Debra Friedman
7 papers
Jiancong Liang
6 papers · 5 as a fellow
MI
Michael Isakoff
6 papers
Eric Shinohara
5 papers
Jonathan Mosley
5 papers
Rashmi Chugh
5 papers
Sara Van Driest
5 papers
Alberto Pappo
4 papers
Dan Roden
4 papers
Huiying Wang
4 papers
Joshua Lawrenz
4 papers

Clinical trials

Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
Site PI · Recruiting · Phase 1
H. Lee Moffitt Cancer Center and Research Institute
2026–2030
Digoxin Medulloblastoma Study
Site PI · Recruiting · Phase 2
H. Lee Moffitt Cancer Center and Research Institute
2026–2027
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2027
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue
Site PI · Recruiting · Phase 1, Phase 2
Nationwide Children's Hospital
2022–2027